{"id":53084,"date":"2023-01-19T12:02:15","date_gmt":"2023-01-19T11:02:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/"},"modified":"2023-01-19T12:02:15","modified_gmt":"2023-01-19T11:02:15","slug":"global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/","title":{"rendered":"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5681661\/global-motion-sickness-drugs-market-2022-2026?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=hrn9vn&amp;utm_campaign=1809760+-+Global+Motion+Sickness+Drugs+Market+2022+to+2026%3A+Featuring+Aurobindo+Pharma%2C+Baxter+International%2C+Caleb+Pharmaceuticals%2C+Cipla+and+CVS+Health+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Motion Sickness Drugs Market 2022-2026&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230119005369\/en\/1690442\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230119005369\/en\/1690442\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe publisher has been monitoring the motion sickness drugs market and it is poised to grow by $119.64 mn during 2022-2026, accelerating at a CAGR of 4.15% during the forecast period.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAurobindo Pharma Ltd\n<\/li>\n<li>\nBaxter International Inc.\n<\/li>\n<li>\nCaleb Pharmaceuticals Inc\n<\/li>\n<li>\nCipla Ltd.\n<\/li>\n<li>\nCVS Health Corp.\n<\/li>\n<li>\nDM Pharma\n<\/li>\n<li>\nDr Reddys Laboratories Ltd\n<\/li>\n<li>\nGlaxoSmithKline Plc\n<\/li>\n<li>\nHylands\n<\/li>\n<li>\nJohnson and Johnson\n<\/li>\n<li>\nLupin Ltd\n<\/li>\n<li>\nMerck KGaA\n<\/li>\n<li>\nMyungmoon Pharm Co. Ltd.\n<\/li>\n<li>\nPerrigo Co. Plc\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nPrestige Consumer Healthcare Inc.\n<\/li>\n<li>\nReliefband Technologies LLC\n<\/li>\n<li>\nViatris Inc.\n<\/li>\n<li>\nWellSpring Pharmaceutical Corp.\n<\/li>\n<li>\nZenomed Healthcare Pvt. Ltd\n<\/li>\n<\/ul>\n<p>\nThis report on the motion sickness drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.\n<\/p>\n<p>\nThis report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the availability of over-the-counter (OTC) drugs, the availability of drugs in multiple dosage forms, and growing tourism worldwide.\n<\/p>\n<p>\nThe motion sickness drugs market analysis includes product segment and geographic landscape. This study identifies the advent of nauseogenic information technology as one of the prime reasons driving the motion sickness drugs market growth during the next few years. Also, the rising trend of virtual reality and growing research on psychosomatic disorders will lead to sizable demand in the market.\n<\/p>\n<p>\nThe publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on the motion sickness drugs market covers the following areas:\n<\/p>\n<ul>\n<li>\nMotion sickness drugs market sizing\n<\/li>\n<li>\nMotion sickness drugs market forecast\n<\/li>\n<li>\nMotion sickness drugs market industry analysis\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>2 Market Landscape<\/strong>\n<\/p>\n<p>\n2.1 Market ecosystem\n<\/p>\n<p>\n<strong>3 Market Sizing<\/strong>\n<\/p>\n<p>\n3.1 Market definition\n<\/p>\n<p>\n3.2 Market segment analysis\n<\/p>\n<p>\n3.3 Market size 2021\n<\/p>\n<p>\n3.4 Market outlook: Forecast for 2021-2026\n<\/p>\n<p>\n<strong>4 Five Forces Analysis<\/strong>\n<\/p>\n<p>\n<strong>5 Market Segmentation by Product<\/strong>\n<\/p>\n<p>\n<strong>6 Customer Landscape<\/strong>\n<\/p>\n<p>\n<strong>7 Geographic Landscape<\/strong>\n<\/p>\n<p>\n<strong>8 Drivers, Challenges, and Trends<\/strong>\n<\/p>\n<p>\n8.1 Market drivers\n<\/p>\n<p>\n8.2 Market challenges\n<\/p>\n<p>\n8.3 Impact of drivers and challenges\n<\/p>\n<p>\n8.4 Market trends\n<\/p>\n<p>\n<strong>9 Vendor Landscape<\/strong>\n<\/p>\n<p>\n<strong>10 Vendor Analysis<\/strong>\n<\/p>\n<p>\n<strong>11 Appendix<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5681661\/global-motion-sickness-drugs-market-2022-2026?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=hrn9vn&amp;utm_campaign=1809760+-+Global+Motion+Sickness+Drugs+Market+2022+to+2026%3A+Featuring+Aurobindo+Pharma%2C+Baxter+International%2C+Caleb+Pharmaceuticals%2C+Cipla+and+CVS+Health+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/bdtglx<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;pr&#x65;&#x73;&#x73;&#x40;&#x72;&#101;&#115;&#101;ar&#x63;&#x68;&#x61;&#x6e;&#x64;&#109;&#97;&#114;ke&#x74;&#x73;&#x2e;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#115;&#x73;&#64;&#x72;&#x65;&#115;&#x65;a&#114;&#x63;h&#97;&#x6e;&#100;&#x6d;a&#114;&#x6b;e&#116;&#x73;&#46;&#x63;&#x6f;&#109;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Motion Sickness Drugs Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The publisher has been monitoring the motion sickness drugs market and it is poised to grow by $119.64 mn during 2022-2026, accelerating at a CAGR of 4.15% during the forecast period. Companies Mentioned Aurobindo Pharma Ltd Baxter International Inc. Caleb &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53084","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Motion Sickness Drugs Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The publisher has been monitoring the motion sickness drugs market and it is poised to grow by $119.64 mn during 2022-2026, accelerating at a CAGR of 4.15% during the forecast period. Companies Mentioned Aurobindo Pharma Ltd Baxter International Inc. Caleb ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-19T11:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230119005369\/en\/1690442\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-01-19T11:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/\"},\"wordCount\":422,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230119005369\\\/en\\\/1690442\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230119005369\\\/en\\\/1690442\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-01-19T11:02:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230119005369\\\/en\\\/1690442\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230119005369\\\/en\\\/1690442\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Motion Sickness Drugs Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The publisher has been monitoring the motion sickness drugs market and it is poised to grow by $119.64 mn during 2022-2026, accelerating at a CAGR of 4.15% during the forecast period. Companies Mentioned Aurobindo Pharma Ltd Baxter International Inc. Caleb ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-19T11:02:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230119005369\/en\/1690442\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others &#8211; ResearchAndMarkets.com","datePublished":"2023-01-19T11:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/"},"wordCount":422,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230119005369\/en\/1690442\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/","name":"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230119005369\/en\/1690442\/21\/logo.jpg","datePublished":"2023-01-19T11:02:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230119005369\/en\/1690442\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230119005369\/en\/1690442\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-motion-sickness-drugs-market-2022-to-2026-featuring-aurobindo-pharma-baxter-international-caleb-pharmaceuticals-cipla-and-cvs-health-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53084"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53084\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}